Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Autoimmune Drugs Market Research Reports

Titlepublishedprice

Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2015

By Global Markets Direct
"...... comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players ......"
22-Jan-2015$2000

Primary Biliary Cirrhosis - Pipeline Review, H1 2015

By Global Markets Direct
"...... alysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the......"
22-Jan-2015$2000

Sjogren's Syndrome - Pipeline Review, H2 2014

By Global Markets Direct
"...... s, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic developmen......"
31-Dec-2014$2000

Anca Vasculitis - Pipeline Review, H2 2014

By Global Markets Direct
"...... eutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anc......"
31-Dec-2014$2000

Pemphigus - Pipeline Review, H2 2014

By Global Markets Direct
"...... by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pemphigus and special......"
31-Dec-2014$2000

Biliary Cirrhosis - Pipeline Review, H2 2014

By Global Markets Direct
"...... therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development f......"
31-Dec-2014$2000

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014

By Global Markets Direct
"...... h comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players......"
31-Dec-2014$2000

Primary Biliary Cirrhosis - Pipeline Review, H2 2014

By Global Markets Direct
"...... ysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the t......"
15-Dec-2014$2000

Myasthenia Gravis - Pipeline Review, H2 2014

By Global Markets Direct
"...... therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development f......"
10-Dec-2014$2000

OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023

By GlobalData
"...... on and there are no preventative medications. The anticipated launch of Alba/Teva’s larazotide acetate in 2018 in the US and 2019 in 5EU, followed by the launch of Alvine/AbbVie’s latiglutenase in 2019 and 2020 in the US and 5EU respectively are set ......"
30-Nov-2014$7995

Avail upto 25% Discount on below Publisher Reports.